Please login to the form below

Not currently logged in
Email:
Password:

Akcea

This page shows the latest Akcea news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Akcea’s rare inherited disorder drug Waylivra

NICE rejects Akcea’s rare inherited disorder drug Waylivra

Akcea’s drug was handed conditional approval by the European Medicines Agency (EMA) last  May, making Europe its first market. ... Waylivra was Akcea’s second drug to reach the market last year after transthyretin-related amyloidosis (ATTR)

Latest news

More from news
Approximately 10 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    Standing in its way is a similarly priced antisense rival from Ionis and Akcea – Tegsedi (inotersen) – as well as Pfizer’s fast- growing Vyndaqel/Vyndamax (tafamidis), which is approved for hATTR

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    two entering the field at the same time. So it is with Alnlyam: Ionis and Akcea secured EMA approval in July for their antisense candidate Tegsedi (inotersen), while Pfizer has just

  • Deal Watch January 2017 Deal Watch January 2017

    As you sow, so shall you reap The use of options is remaining widespread as noted in the Novartis deal with Ionis and Akcea. ... 1, 700. Ionis | Akcea. Novartis. Exclusive option to licence. AKCEA-APOCIII-LRx for heart failure.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Mind+Matter Mind+Matter

    Our clients span the full spectrum of health – from deep pharma, to consumer health, healthy beauty and animal health.  They include: Aerogen,  Akcea,  Allakos, Alexion,  Amylyx Pharmaceuticals, Astellas, Baxter Healthcare, Bayer,

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics